This week, Dr. Peter Mugyenyi is visiting Washington from Uganda, where he directs the Joint Clinical Research Center, the largest PEPFAR implementer in East Africa. Dr. Mugyenyi was one of a half-dozen people in the room when PEPFAR was conceived back in 2003. As one of the program’s most eloquent supporters, Dr. Mugyenyi has recently begun voicing grave concern about the near flat-funding of PEPFAR’s budget. In this video interview, he talks about the on-the-ground consequences of a pullback from the fight against global AIDS. Dr. Mugyenyi will be testifying about this issue on Thursday at a hearing before a House Foreign Affairs subcommittee.
U.S. drug costs lead to lapsed treatment adherence, less viral suppression, more ER, hospital visits for people with HIV, study finds
From 2016 to 2017, 14% of people living with HIV in the United States did something to save money on the out-of-pocket costs of their prescription […]
Combatting MDR TB: Year three – Released four years ago, the federal National Action Plan for Combating Multidrug-Resistant Tuberculosis raised hopes that targets and strategies would […]
This year marks the close of a dynamic decade in global infectious disease research and responses that changed expectations of what humanity can accomplish toward making […]
Wuhan City in the Hubei Province of the People’s Republic of China is on the Yangtze River and is the most populous city in central China. […]